<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="deo270003" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">DEN Open</journal-id><journal-id journal-id-type="iso-abbrev">DEN Open</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2692-4609</journal-id><journal-id journal-id-type="publisher-id">DEO2</journal-id><journal-title-group><journal-title>DEN Open</journal-title></journal-title-group><issn pub-type="epub">2692-4609</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39268174</article-id><article-id pub-id-type="pmc">PMC11391100</article-id>
<article-id pub-id-type="doi">10.1002/deo2.70003</article-id><article-id pub-id-type="publisher-id">DEO270003</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Comparative analyses of short&#x02010; and long&#x02010;term outcomes between endoscopic submucosal dissection and endoscopic laryngo&#x02010;pharyngeal surgery for superficial pharyngeal carcinomas</article-title><alt-title alt-title-type="left-running-head">FUKUHARA <sc>et&#x000a0;al.</sc>
</alt-title></title-group><contrib-group><contrib id="deo270003-cr-0001" contrib-type="author"><name><surname>Fukuhara</surname><given-names>Motomitsu</given-names></name><xref rid="deo270003-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270003-cr-0002" contrib-type="author" corresp="yes"><name><surname>Urabe</surname><given-names>Yuji</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0009-9851-8564</contrib-id><xref rid="deo270003-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>beyan13@hiroshima-u.ac.jp</email></address></contrib><contrib id="deo270003-cr-0003" contrib-type="author"><name><surname>Nakamura</surname><given-names>Takeo</given-names></name><xref rid="deo270003-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270003-cr-0004" contrib-type="author"><name><surname>Ishibashi</surname><given-names>Kazuki</given-names></name><xref rid="deo270003-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270003-cr-0005" contrib-type="author"><name><surname>Konishi</surname><given-names>Hirona</given-names></name><xref rid="deo270003-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270003-cr-0006" contrib-type="author"><name><surname>Mizuno</surname><given-names>Junichi</given-names></name><xref rid="deo270003-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270003-cr-0007" contrib-type="author"><name><surname>Takasago</surname><given-names>Takeshi</given-names></name><xref rid="deo270003-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270003-cr-0008" contrib-type="author"><name><surname>Tanaka</surname><given-names>Hidenori</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3646-5796</contrib-id><xref rid="deo270003-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270003-cr-0009" contrib-type="author"><name><surname>Tsuboi</surname><given-names>Akiyoshi</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4154-658X</contrib-id><xref rid="deo270003-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270003-cr-0010" contrib-type="author"><name><surname>Yamashita</surname><given-names>Ken</given-names></name><xref rid="deo270003-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270003-cr-0011" contrib-type="author"><name><surname>Hiyama</surname><given-names>Yuichi</given-names></name><xref rid="deo270003-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="deo270003-cr-0012" contrib-type="author"><name><surname>Takigawa</surname><given-names>Hidehiko</given-names></name><xref rid="deo270003-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270003-cr-0013" contrib-type="author"><name><surname>Kotachi</surname><given-names>Takahiro</given-names></name><xref rid="deo270003-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270003-cr-0014" contrib-type="author"><name><surname>Yuge</surname><given-names>Ryo</given-names></name><xref rid="deo270003-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="deo270003-cr-0015" contrib-type="author"><name><surname>Ishikawa</surname><given-names>Akira</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1528-1939</contrib-id><xref rid="deo270003-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="deo270003-cr-0016" contrib-type="author"><name><surname>Taruya</surname><given-names>Takayuki</given-names></name><xref rid="deo270003-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="deo270003-cr-0017" contrib-type="author"><name><surname>Ueda</surname><given-names>Tsutomu</given-names></name><xref rid="deo270003-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="deo270003-cr-0018" contrib-type="author"><name><surname>Takeno</surname><given-names>Sachio</given-names></name><xref rid="deo270003-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="deo270003-cr-0019" contrib-type="author"><name><surname>Oka</surname><given-names>Shiro</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1652-0743</contrib-id><xref rid="deo270003-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="deo270003-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Gastroenterology</named-content>
<named-content content-type="organisation-division">Graduate School of Biomedical and Health Sciences</named-content>
<institution>Hiroshima University</institution>
<named-content content-type="country-part">Hiroshima</named-content>
<country country="JP">Japan</country>
</aff><aff id="deo270003-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Gastrointestinal Endoscopy and Medicine</named-content>
<institution>Hiroshima University Hospital</institution>
<named-content content-type="country-part">Hiroshima</named-content>
<country country="JP">Japan</country>
</aff><aff id="deo270003-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Clinical Research Center</named-content>
<institution>Hiroshima University Hospital</institution>
<named-content content-type="country-part">Hiroshima</named-content>
<country country="JP">Japan</country>
</aff><aff id="deo270003-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Molecular Pathology</named-content>
<named-content content-type="organisation-division">Graduate School of Biomedical and Health Sciences</named-content>
<institution>Hiroshima University</institution>
<named-content content-type="country-part">Hiroshima</named-content>
<country country="JP">Japan</country>
</aff><aff id="deo270003-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Otorhinolaryngology</named-content>
<named-content content-type="organisation-division">Head and Neck Surgery</named-content>
<named-content content-type="organisation-division">Graduate School of Biomedical Sciences</named-content>
<institution>Hiroshima University</institution>
<named-content content-type="country-part">Hiroshima</named-content>
<country country="JP">Japan</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence</bold>
<break/>Yuji Urabe, Gastrointestinal Endoscopy and Medicine, Hiroshima University Hospital, 1&#x02010;2&#x02010;3, Kasumi, Minamiku, Hiroshima 734&#x02013;8551, Japan.<break/> Email: <email>beyan13@hiroshima-u.ac.jp</email>
<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>12</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2025</year></pub-date><volume>5</volume><issue seq="88">1</issue><issue-id pub-id-type="doi">10.1002/deo2.v5.1</issue-id><elocation-id>e70003</elocation-id><history>
<date date-type="rev-recd"><day>02</day><month>8</month><year>2024</year></date>
<date date-type="received"><day>06</day><month>1</month><year>2024</year></date>
<date date-type="accepted"><day>08</day><month>8</month><year>2024</year></date>
</history><permissions><!--&#x000a9; 2025 John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2024 The Author(s). <italic toggle="yes">DEN Open</italic> published by John Wiley &#x00026; Sons Australia, Ltd on behalf of Japan Gastroenterological Endoscopy Society.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:DEO2-5-e70003.pdf"/><abstract><title>Abstract</title><sec id="deo270003-sec-0010"><title>Objectives</title><p>Endoscopic treatment of superficial pharyngeal carcinomas includes endoscopic submucosal dissection (ESD; usually performed by endoscopists), and endoscopic laryngo&#x02010;pharyngeal surgery (ELPS; primarily performed by otolaryngologists). Few studies have compared the efficacy of the two techniques in treating superficial pharyngeal carcinomas. In this study, we compared the outcomes of these two techniques to determine the advantages.</p></sec><sec id="deo270003-sec-0020"><title>Methods</title><p>We retrospectively examined the short&#x02010; and long&#x02010;term outcomes of 93 consecutive patients with superficial pharyngeal carcinoma who either underwent an ESD or ELPS between August 2008 and December 2021.</p></sec><sec id="deo270003-sec-0030"><title>Results</title><p>There were 35 lesions among 29 patients and 93 lesions among 71 patients in the ESD and ELPS groups, respectively. The ELPS group had a significantly shorter procedure time (121.2 &#x000b1; 97.4 min vs. 54.7 &#x000b1; 40.2 min, p&#x0003c;0.01), greater procedure speed (0.10 &#x000b1; 0.06 min/min vs. 0.30 &#x000b1; 0.23 min/min, p&#x0003c;0.01), and less laryngeal edema than that of the ESD group. There were no significant differences in the 3&#x02010;year overall, relapse&#x02010;free, or disease&#x02010;specific survival rates between the two groups. Intervention with ESD during ELPS was most commonly required when it was difficult to secure the visual field.</p></sec><sec id="deo270003-sec-0040"><title>Conclusions</title><p>There were no differences in batch resection rates or long&#x02010;term prognoses between the two groups; nevertheless, the ELPS group had a shorter treatment time and less laryngeal edema than the ESD group. However, the treatment of narrow areas, such as the esophageal inlet patch, is a technical limitation of ELPS; thus, ELPS should be combined with ESD techniques.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="deo270003-kwd-0001">endoscopic submucosal dissection</kwd><kwd id="deo270003-kwd-0002">head and neck squamous cell carcinomas</kwd><kwd id="deo270003-kwd-0003">otorhinolaryngological surgical procedures</kwd><kwd id="deo270003-kwd-0004">squamous cell carcinoma of the head and neck</kwd><kwd id="deo270003-kwd-0005">surgical procedures</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>None</funding-source></award-group></funding-group><counts><fig-count count="2"/><table-count count="6"/><page-count count="9"/><word-count count="5314"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:27.02.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="deo270003-sec-0050"><title>INTRODUCTION</title><p>Laryngopharyngeal carcinoma is frequently in an advanced stage at detection and has a relatively poor prognosis.<xref rid="deo270003-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> Advanced laryngopharyngeal carcinomas require either a total laryngectomy or chemoradiotherapy and considerably reduce laryngeal function and the quality of life.<xref rid="deo270003-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> Early detection of tumors is crucial for increasing survival rates and minimizing functional impairments of swallowing and voice. Recently, the development and widespread use of diagnostic imaging techniques such as narrow&#x02010;band imaging have enabled the early detection of superficial pharyngeal carcinomas.<xref rid="deo270003-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>
</p><p>Endoscopic resection is the first choice of treatment for superficial pharyngeal carcinomas (SPCs) owing to its excellent outcomes and low incidence of complications.<xref rid="deo270003-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref> Endoscopic resection for SPCs is more advantageous than endoscopic treatment for other organs because of the possibility of organ preservation and the high quality of life after surgery.<xref rid="deo270003-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> Endoscopic treatment of SPCs has been performed using endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), extrapolated from the guidelines for the endoscopic treatment of esophageal and gastric carcinomas. In 2004, Omori et&#x000a0;al. developed endoscopic laryngo&#x02010;pharyngeal surgery (ELPS), in which the larynx is expanded using a&#x000a0;curved rigid&#x000a0;laryngoscope, forceps or electrocautery is inserted trans&#x02010;orally, and endoscopically assisted dissection of the subepithelial layer beneath the lesion is performed.<xref rid="deo270003-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> Thus far, few studies have compared ELPS and ESD in the management of SPCs. Furthermore, the indications for these techniques are unclear. In this study, we compared the short&#x02010; and long&#x02010;term outcomes of ESD and ELPS at our institution to determine the advantages of these two techniques.</p></sec><sec id="deo270003-sec-0060"><title>METHODS</title><sec id="deo270003-sec-0070"><title>Ethical considerations</title><p>All enrolled participants were informed of the risks and benefits of ESD and ELPS and provided written informed consent for the use of their data. This study was approved by the Institutional Review Board of Hiroshima University Hospital (approval number: E2021&#x02010;2657) and was conducted in accordance with the principles of the Declaration of Helsinki.</p></sec><sec id="deo270003-sec-0080"><title>Study design and population</title><p>We retrospectively enrolled consecutive patients with SPCs who underwent ESD and ELPS at Hiroshima University Hospital between August 2008 and December 2021. Until September 2014, all patients were treated using ESD, and after October 2014, they were treated using ELPS. However, in cases where treatment with ELPS was technically impossible, such as when the ELPS forceps could not reach the patient, ESD was used from the beginning.</p><p>The patients were divided into two groups: the ESD group (patients who underwent ESD alone) and the ELPS group (patients who underwent ELPS; Figure&#x000a0;<xref rid="deo270003-fig-0001" ref-type="fig">1</xref>). We analyzed and compared the treatment outcomes between these two groups. The indications for concomitant ESD were analyzed for the patients in the ELPS group. Moreover, the long&#x02010;term prognosis was compared between the two groups to examine the 3&#x02010;year prognosis until the final date of December 2022.</p><fig position="float" fig-type="FIGURE" id="deo270003-fig-0001"><label>FIGURE 1</label><caption><p>Study flowchart depicting the comparison of the short&#x02010;term outcomes between the patients who underwent ESD (the ESD group) and those who underwent ELPS (the ELPS group) for SPCs. ESD, endoscopic submucosal dissection; ELPS, endoscopic laryngo&#x02010;pharyngeal surgery; SPC, superficial pharyngeal carcinoma</p></caption><graphic xlink:href="DEO2-5-e70003-g001" position="anchor" id="jats-graphic-1"/></fig></sec><sec id="deo270003-sec-0090"><title>ELPS and ESD procedures</title><p>All procedures were performed under general anesthesia using a curved rigid laryngoscope (Nagashima Medical Instruments Company, Ltd.) to create a working space. A magnifying endoscope (GIF&#x02010;H260Z or GIF&#x02010;H290Z; Olympus Co.) was used for observation before treatment, and a single&#x02010;channel upper gastrointestinal endoscope with a water&#x02010;jet system (GIF&#x02010;Q260 J; Olympus) was used during treatment. The extent of the lesion was determined by the findings of the narrow&#x02010;band imaging endoscopic examination and iodine staining.</p><p>For ESD, a solution consisting of glycerin (10%) and indigo carmine (0.005%) was injected into the submucosal layer for lifting. Next, the lesion was marked using DualKnife or DualKnife J (Olympus Medical Systems), and an incision and dissection were performed. During this procedure, gastroenterologists performed the resection with the assistance of an otolaryngologist. We used clip&#x02010;line traction in all cases.</p><p>For ELPS, after the submucosal injection and lifting, the lesion was resected manually using a curved needle knife (Olympus Optical Co.) and curved or Steiner's forceps. The resection was performed by otolaryngologists, with the assistance of gastrointestinal endoscopists. Traction was performed with forceps in all patients. In cases where the otorhinolaryngologist determined that resection or dissection with ELPS was difficult, ESD techniques were used in combination. The decision to return to the ELPS was reached after mutual consultation between the gastrointestinal endoscopist and otolaryngologist. These patients were treated using ELPS to the greatest extent possible. A needle scalpel was used when the ESD technique was performed during ELPS. If pre&#x02010;operative assessment determined that ELPS would not be possible, such as in cases where the patient had a narrow oral cavity, the tumor was treated using only the ESD technique. ESG100 electrosurgical generators (Olympus) were used until 2009; thereafter, VIO300D generators (ERBE Elektromedizin GmbH) were used. The two gastrointestinal endoscopists who performed the treatments were certified by the Japan Gastroenterological Endoscopy Society and had &#x0003e;10 years of medical experience, involving &#x0003e;100 ESD cases. The otolaryngologist is a well&#x02010;trained head and neck surgeon, and the two endoscopists all had &#x0003e; 10 years of case experience. We followed up with an endoscopy and cervical echocardiography every 6 months as a post&#x02010;treatment follow&#x02010;up.</p></sec><sec id="deo270003-sec-0100"><title>Definitions</title><p>Definitions are presented in detail in <xref rid="deo270003-supitem-0001" ref-type="supplementary-material">Supporting Information 1</xref>.</p></sec><sec id="deo270003-sec-0110"><title>Pathological examinations</title><p>Pathological examinations are presented in detail in <xref rid="deo270003-supitem-0001" ref-type="supplementary-material">Supporting Information 1</xref>.</p></sec><sec id="deo270003-sec-0120"><title>Evaluation</title><p>The primary outcomes were the complete resection rate and prognosis. The secondary outcomes were the procedure time, histopathologic findings, and adverse event occurrence. Moreover, we investigated the clinical characteristics of lesions that required resection with ESD techniques in patients in the ELPS group.</p></sec><sec id="deo270003-sec-0130"><title>Statistical analyses</title><p>Categorical variables, expressed as percentages, were statistically compared using the chi&#x02010;square and Fisher's exact tests. Continuous variables, expressed as means &#x000b1; standard deviations or as medians (ranges), were compared using Student's t&#x02010;test. The Kaplan&#x02013;Meier method was used to calculate survival rates. The log&#x02010;rank test was used to compare survival curves in the univariate analysis. Statistical analyses were performed using JMP version 15 (SAS Institute Inc.). Statistical significance was set at <italic toggle="yes">p</italic> &#x0003c; 0.05.</p></sec></sec><sec id="deo270003-sec-0140"><title>RESULTS</title><sec id="deo270003-sec-0150"><title>Participant and tumor characteristics</title><p>We enrolled 93 patients (128 SPCs) who underwent ESD or ELPS (Figure&#x000a0;<xref rid="deo270003-fig-0001" ref-type="fig">1</xref>). The characteristics of the patients and tumors are presented in Table&#x000a0;<xref rid="deo270003-tbl-0001" ref-type="table">1</xref>. The ESD and ELPS groups included 29 (35 lesions) and 71 patients (93 lesions), respectively. The characteristics of the patients and tumors for the ESD and ELPS groups are shown in Table&#x000a0;<xref rid="deo270003-tbl-0002" ref-type="table">2</xref>. The observation period was significantly longer in the ESD group than in the ELPS group (87.6 &#x000b1; 51.1 months vs. 37.7 &#x000b1; 23.8 months, <italic toggle="yes">p</italic> &#x0003c; 0.01).</p><table-wrap position="float" id="deo270003-tbl-0001" content-type="TABLE"><label>TABLE 1</label><caption><p>Overall patient and tumor characteristics.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Variables</th><th align="left" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, years, mean &#x000b1; SD</td><td align="left" rowspan="1" colspan="1">68.2 &#x000b1; 9.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Male, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">119 (93.0)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Female, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">009 (07.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">JCOG&#x02010;PS</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">109 (85.2)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">017 (13.2)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">002 (01.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Observation period (months), mean &#x000b1; SD</td><td align="left" rowspan="1" colspan="1">51.4 &#x000b1; 40.1</td></tr><tr><td align="left" rowspan="1" colspan="1">Location</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Oropharynx, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">028 (21.9)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Posterior wall</td><td align="left" rowspan="1" colspan="1">015 (11.8)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Lateral wall</td><td align="left" rowspan="1" colspan="1">004 (03.1)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Anterior wall</td><td align="left" rowspan="1" colspan="1">009 (07.0)</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypopharynx, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">100 (78.1)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Pyriform sinus</td><td align="left" rowspan="1" colspan="1">082 (64.0)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Postcricoid</td><td align="left" rowspan="1" colspan="1">001 (00.8)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Posterior wall</td><td align="left" rowspan="1" colspan="1">013 (10.2)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Esophageal inlet</td><td align="left" rowspan="1" colspan="1">004 (03.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Tumor size, mm, mean &#x000b1; SD</td><td align="left" rowspan="1" colspan="1">22.9 &#x000b1; 11.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Macroscopic type</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">0&#x02010;I, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">017 (13.3)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">0&#x02010;IIa, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">057 (44.5)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">0&#x02010;IIb, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">037 (28.9)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">0&#x02010;IIc, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">017 (13.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">JES&#x02010;SCC</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Type B1 vessels, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">097 (75.8)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Type B2 vessels, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">021 (16.4)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">Type B3 vessels, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">010 (07.8)</td></tr><tr><td align="left" rowspan="1" colspan="1">Procedure</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">ESD</td><td align="left" rowspan="1" colspan="1">035 (27.3)</td></tr><tr><td align="left" style="padding-left:10%" rowspan="1" colspan="1">ELPS</td><td align="left" rowspan="1" colspan="1">093 (72.7)</td></tr></tbody></table><table-wrap-foot><fn id="deo270003-tbl1-note-0001"><p>There were 128 lesions in 93 patients who underwent ESD/ELPS for superficial pharynx squamous cell carcinoma between August 2008 and December 2021.</p></fn><fn id="deo270003-tbl1-note-0002"><p>Abbreviations: ELPS, endoscopic laryngo&#x02010;pharyngeal surgery; ESD, endoscopic submucosal dissection; JCOG&#x02010;PS, Japan Clinical Oncology Group Performance Status; JES, Japan Esophageal Society; SCC, squamous cell carcinoma; SD, standard deviation.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap position="float" id="deo270003-tbl-0002" content-type="TABLE"><label>TABLE 2</label><caption><p>Patient and tumor characteristics of endoscopic submucosal dissection/endoscopic laryngo&#x02010;pharyngeal surgery.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">ESD group</th><th align="left" rowspan="1" colspan="1">ELPS group</th><th align="left" rowspan="1" colspan="1"/></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Variables</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> = 35</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> = 93</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age, years, mean &#x000b1; SD</td><td align="left" rowspan="1" colspan="1">66.9 &#x000b1; 10.4</td><td align="left" rowspan="1" colspan="1">68.7 &#x000b1; 8.6</td><td align="char" rowspan="1" colspan="1">0.3364</td></tr><tr><td align="left" rowspan="1" colspan="1">Sex</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Male, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">33 (94.3)</td><td align="left" rowspan="1" colspan="1">86 (92.5)</td><td align="char" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Female, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">02 (05.7)</td><td align="left" rowspan="1" colspan="1">07 (07.5)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">JCOG&#x02010;PS</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">29 (82.9)</td><td align="left" rowspan="1" colspan="1">80 (86.0)</td><td align="char" rowspan="1" colspan="1">0.7807</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">1/ 2</td><td align="left" rowspan="1" colspan="1">06 (17.1)</td><td align="left" rowspan="1" colspan="1">11 (14.0)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Observation period (months), mean &#x000b1; SD</td><td align="left" rowspan="1" colspan="1">87.6 &#x000b1; 51.1</td><td align="left" rowspan="1" colspan="1">37.7 &#x000b1; 23.8</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Location</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Oropharynx, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">07 (20.0)</td><td align="left" rowspan="1" colspan="1">21 (22.6)</td><td align="char" rowspan="1" colspan="1">0.8153</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Posterior wall</td><td align="left" rowspan="1" colspan="1">05 (14.3)</td><td align="left" rowspan="1" colspan="1">10 (10.8)</td><td align="char" rowspan="1" colspan="1">0.5522</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Lateral wall</td><td align="left" rowspan="1" colspan="1">00 (00.0)</td><td align="left" rowspan="1" colspan="1">04 (04.3)</td><td align="char" rowspan="1" colspan="1">0.5743</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Anterior wall</td><td align="left" rowspan="1" colspan="1">02 (05.7)</td><td align="left" rowspan="1" colspan="1">07 (07.5)</td><td align="char" rowspan="1" colspan="1">1.0000</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypopharynx, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">28 (80.0)</td><td align="left" rowspan="1" colspan="1">72 (77.4)</td><td align="char" rowspan="1" colspan="1">0.8153</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Pyriform sinus</td><td align="left" rowspan="1" colspan="1">21 (60.0)</td><td align="left" rowspan="1" colspan="1">61 (65.6)</td><td align="char" rowspan="1" colspan="1">0.6798</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Postcricoid</td><td align="left" rowspan="1" colspan="1">00 (00.0)</td><td align="left" rowspan="1" colspan="1">01 (01.1)</td><td align="char" rowspan="1" colspan="1">1.0000</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Posterior wall</td><td align="left" rowspan="1" colspan="1">04 (11.4)</td><td align="left" rowspan="1" colspan="1">09 (09.7)</td><td align="char" rowspan="1" colspan="1">0.7502</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Esophageal inlet</td><td align="left" rowspan="1" colspan="1">03 (08.6)</td><td align="left" rowspan="1" colspan="1">01 (01.1)</td><td align="char" rowspan="1" colspan="1">0.0620</td></tr><tr><td align="left" rowspan="1" colspan="1">Tumor size, mean &#x000b1; SD</td><td align="left" rowspan="1" colspan="1">21.9 &#x000b1; 11.1</td><td align="left" rowspan="1" colspan="1">23.3 &#x000b1; 11.5</td><td align="char" rowspan="1" colspan="1">0.5363</td></tr><tr><td align="left" rowspan="1" colspan="1">Macroscopic type</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">0&#x02010;I, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">03 (08.6)</td><td align="left" rowspan="1" colspan="1">14 (15.1)</td><td align="char" rowspan="1" colspan="1">0.3982</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">0&#x02010;IIa, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">18 (51.4)</td><td align="left" rowspan="1" colspan="1">39 (41.9)</td><td align="char" rowspan="1" colspan="1">0.3364</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">0&#x02010;IIb, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">12 (34.3)</td><td align="left" rowspan="1" colspan="1">25 (26.9)</td><td align="char" rowspan="1" colspan="1">0.4149</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">0&#x02010;IIc, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">02 (05.7)</td><td align="left" rowspan="1" colspan="1">15 (16.1)</td><td align="char" rowspan="1" colspan="1">0.1520</td></tr><tr><td align="left" rowspan="1" colspan="1">JES&#x02010;SCC</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Type B1 vessels, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">30 (85.7)</td><td align="left" rowspan="1" colspan="1">67 (72.0)</td><td align="char" rowspan="1" colspan="1">0.1638</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Type B2 vessels, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">05 (14.3)</td><td align="left" rowspan="1" colspan="1">16 (17.2)</td><td align="char" rowspan="1" colspan="1">0.7940</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Type B3 vessels, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">00 (00.0)</td><td align="left" rowspan="1" colspan="1">10 (10.8)</td><td align="char" rowspan="1" colspan="1">0.0608</td></tr></tbody></table><table-wrap-foot><fn id="deo270003-tbl2-note-0001"><p>We categorized all 128 lesions in 93 patients into the ESD and ELPS groups. The ESD group included 35 lesions in 29 patients. The ELPS group included 93 lesions in 71 patients.</p></fn><fn id="deo270003-tbl2-note-0002"><p>Abbreviations: ELPS, endoscopic laryngo&#x02010;pharyngeal surgery; ESD, endoscopic submucosal dissection; JCOG&#x02010;PS, Japan Clinical Oncology Group Performance Status; JES, Japan Esophageal Society; SCC, squamous cell carcinoma; SD, standard deviation.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="deo270003-sec-0160"><title>Short&#x02010;term treatment outcomes</title><p>The short&#x02010;term treatment outcomes are presented in Table&#x000a0;<xref rid="deo270003-tbl-0003" ref-type="table">3</xref>. The ELPS group had a significantly shorter procedure time (121.2 &#x000b1; 97.4 min vs. 54.7 &#x000b1; 40.2 min, <italic toggle="yes">p</italic> &#x0003c; 0.01) and greater procedure speed (0.10 &#x000b1; 0.06 min/min vs. 0.30 &#x000b1; 0.23 min/min, <italic toggle="yes">p</italic> &#x0003c; 0.01) than that of the ESD group. Laryngeal edema incidence was significantly lower in the ELPS group than in the ESD group (85.7% [30/35] vs. 54.8% [51/93], <italic toggle="yes">p</italic> &#x0003c; 0.01).</p><table-wrap position="float" id="deo270003-tbl-0003" content-type="TABLE"><label>TABLE 3</label><caption><p>Short&#x02010;term treatment outcomes of the endoscopic submucosal dissection and endoscopic laryngo&#x02010;pharyngeal surgery groups.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">ESD group</th><th align="left" rowspan="1" colspan="1">ELPS group</th><th align="char" rowspan="1" colspan="1"/></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Variables</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> = 35</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> = 93</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">En bloc resection, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">34 (97.1)</td><td align="left" rowspan="1" colspan="1">92 (98.9)</td><td align="char" rowspan="1" colspan="1">0.4737</td></tr><tr><td align="left" rowspan="1" colspan="1">Complete en bloc resection, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">32 (91.4)</td><td align="left" rowspan="1" colspan="1">90 (96.8)</td><td align="char" rowspan="1" colspan="1">0.3443</td></tr><tr><td align="left" rowspan="1" colspan="1">Resection size, mean &#x000b1; SD</td><td align="left" rowspan="1" colspan="1">36.6 &#x000b1; 13.7</td><td align="left" rowspan="1" colspan="1">38.0 &#x000b1; 13.3</td><td align="char" rowspan="1" colspan="1">0.6003</td></tr><tr><td align="left" rowspan="1" colspan="1">Procedure time (min), mean &#x000b1; SD</td><td align="left" rowspan="1" colspan="1">121.2 &#x000b1; 97.4</td><td align="left" rowspan="1" colspan="1">54.7 &#x000b1; 40.2</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Procedure speed (cm<sup>2</sup> /min), mean &#x000b1; SD</td><td align="left" rowspan="1" colspan="1">0.10 &#x000b1; 0.06</td><td align="left" rowspan="1" colspan="1">0.30 &#x000b1; 0.23</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Depth of tumor invasion</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">CIS, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">21 (60.0)</td><td align="left" rowspan="1" colspan="1">52 (55.9)</td><td align="char" rowspan="1" colspan="1">0.6947</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">SEP, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">14 (40.0)</td><td align="left" rowspan="1" colspan="1">41 (44.1)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:15%" align="left" rowspan="1" colspan="1">Tumor thickness &#x0003c; 1000 &#x000b5;m, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">12 (85.7)</td><td align="left" rowspan="1" colspan="1">23 (56.1)</td><td align="char" rowspan="1" colspan="1">0.0587</td></tr><tr><td style="padding-left:15%" align="left" rowspan="1" colspan="1">Tumor thickness &#x02265; 1000 &#x000b5;m, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">02 (14.3)</td><td align="left" rowspan="1" colspan="1">18 (43.9)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Vascular invasion, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">01 (2.9)</td><td align="left" rowspan="1" colspan="1">08 (8.6)</td><td align="char" rowspan="1" colspan="1">0.4426</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphatic invasion, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">00 (.0)</td><td align="left" rowspan="1" colspan="1">04 (4.3)</td><td align="char" rowspan="1" colspan="1">0.5743</td></tr><tr><td align="left" rowspan="1" colspan="1">Adverse events</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Laryngeal edema</td><td align="left" rowspan="1" colspan="1">30 (85.7)</td><td align="left" rowspan="1" colspan="1">51 (54.8)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Delayed bleeding, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">01 (2.9)</td><td align="left" rowspan="1" colspan="1">02 (2.2)</td><td align="char" rowspan="1" colspan="1">1</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Dysphagia, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">11 (31.4)</td><td align="left" rowspan="1" colspan="1">17 (18.3)</td><td align="char" rowspan="1" colspan="1">0.1179</td></tr></tbody></table><table-wrap-foot><fn id="deo270003-tbl3-note-0001"><p>We categorized all 128 lesions among the 93 patients into the ESD and ELPS groups. The ESD group includes 35 lesions among 29 patients. The ELPS group includes 93 lesions among 71 patients.</p></fn><fn id="deo270003-tbl3-note-0002"><p>Abbreviations: CIS, carcinoma in situ; ELPS, endoscopic laryngo&#x02010;pharyngeal surgery; ESD, endoscopic submucosal resection; SD, standard deviation; SEP, subepithelial propria.</p></fn><fn id="deo270003-tbl3-note-0003"><label>*</label><p>Statistical significance was set at <italic toggle="yes">p</italic> &#x0003c; 0.05.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="deo270003-sec-0170"><title>Combination treatment with ELPS and ESD</title><p>We investigated the indications that led to the use of the ESD technique (35/101, 35%). The indications for combination treatment with ELPS and ESD are shown in Table&#x000a0;<xref rid="deo270003-tbl-0004" ref-type="table">4</xref>. The most common indication (22 lesions; 62.9%) was &#x0201c;difficulty in securing the visual field due to the location of the lesion adjacent to the esophageal inlet patch.&#x0201d; This was followed by the indication &#x0201c;incision along the upper aspect of the glottis&#x0201d; (four lesions; 11.1%).</p><table-wrap position="float" id="deo270003-tbl-0004" content-type="TABLE"><label>TABLE 4</label><caption><p>Indications for concomitant treatment using both the endoscopic submucosal dissection and endoscopic laryngo&#x02010;pharyngeal surgery techniques.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Variables</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> = 35</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Difficulty in securing the visual field due to the location of the lesion adjacent to the esophageal inlet patch, <italic toggle="yes">n</italic> (%)</td><td align="center" rowspan="1" colspan="1">22 (62.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">An incision along the upper aspect of the glottis, <italic toggle="yes">n</italic> (%)</td><td align="center" rowspan="1" colspan="1">04 (11.1)</td></tr><tr><td align="left" rowspan="1" colspan="1">Difficulty in securing the visual field due to the location of the lesion at the tongue root, <italic toggle="yes">n</italic> (%)</td><td align="center" rowspan="1" colspan="1">03 (8.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Narrow surgical field, <italic toggle="yes">n</italic> (%)</td><td align="center" rowspan="1" colspan="1">03 (8.6)</td></tr><tr><td align="left" rowspan="1" colspan="1">Difficulty in securing the visual field due to the location of the lesion at the pharyngeal&#x02013;jejunal anastomosis, <italic toggle="yes">n</italic> (%)</td><td align="center" rowspan="1" colspan="1">01 (2.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">An incision along the nasopharyngeal aspect, <italic toggle="yes">n</italic> (%)</td><td align="center" rowspan="1" colspan="1">01 (2.9)</td></tr><tr><td align="left" rowspan="1" colspan="1">Initial introduction of ELPS, <italic toggle="yes">n</italic> (%), <italic toggle="yes">n</italic> (%)</td><td align="center" rowspan="1" colspan="1">01 (2.9)</td></tr></tbody></table><table-wrap-foot><fn id="deo270003-tbl4-note-0001"><p>The indications for the ESD technique for 35 lesions are shown; it was either chosen during treatment, when the ELPS technique proved challenging, or preoperatively when the ESD technique was expected to be less challenging than the ELPS technique.</p></fn><fn id="deo270003-tbl4-note-0002"><p>Abbreviations: ELPS, endoscopic laryngo&#x02010;pharyngeal surgery; ESD, endoscopic submucosal resection.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Additionally, 27 lesions adjacent to the esophageal inlet were classified into ESD&#x02010;alone (eight lesions) and ELPS+ESD (19 lesions) groups. Table&#x000a0;<xref rid="deo270003-tbl-0005" ref-type="table">5</xref> presents the short&#x02010;term outcomes for lesions near the esophageal inlet in the ESD&#x02010;alone and ELPS+ESD groups. No difference was found in the complete en bloc resection rate between the two groups. Additionally, no difference was found in the resection size; however, the ELPS+ESD group had shorter procedure times (140 &#x000b1; 24.5 vs. 75.4 &#x000b1; 50.9 min, <italic toggle="yes">p</italic> &#x0003c; 0.01) and faster operative speeds (0.08 &#x000b1; 0.02 vs. 0.26 &#x000b1; 0.15 cm<sup>2</sup>/min, <italic toggle="yes">p</italic> &#x0003c; 0.01) than did the ESD&#x02010;alone group. The rate of laryngeal edema did not differ between the two groups.</p><table-wrap position="float" id="deo270003-tbl-0005" content-type="TABLE"><label>TABLE 5</label><caption><p>Comparison of outcomes of the endoscopic submucosal dissection and endoscopic laryngo&#x02010;pharyngeal surgery + endoscopic submucosal dissection groups for lesions near the esophageal inlet.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">ESD&#x02010;group</th><th align="left" rowspan="1" colspan="1">ELPS+ESD group</th><th align="char" rowspan="1" colspan="1"/></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Variables</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> = 8</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> = 19</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">En bloc resection, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">08 (100)</td><td align="left" rowspan="1" colspan="1">19 (100)</td><td align="char" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Complete en bloc resection, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">07 (87.5)</td><td align="left" rowspan="1" colspan="1">19 (100)</td><td align="char" rowspan="1" colspan="1">0.2963</td></tr><tr><td align="left" rowspan="1" colspan="1">Resection size, mean &#x000b1; SD</td><td align="left" rowspan="1" colspan="1">40.6 &#x000b1; 7.7</td><td align="left" rowspan="1" colspan="1">41.3 &#x000b1; 15.2</td><td align="char" rowspan="1" colspan="1">0.7410</td></tr><tr><td align="left" rowspan="1" colspan="1">Procedure time (min), mean &#x000b1; SD</td><td align="left" rowspan="1" colspan="1">140 &#x000b1; 24.5</td><td align="left" rowspan="1" colspan="1">75.4 &#x000b1; 50.9</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Procedure speed (cm<sup>2</sup>/min), mean &#x000b1; SD</td><td align="left" rowspan="1" colspan="1">0.08 &#x000b1; 0.02</td><td align="left" rowspan="1" colspan="1">0.26 &#x000b1; 0.15</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Depth of tumor invasion</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">CIS, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">04 (50.0)</td><td align="left" rowspan="1" colspan="1">12 (63.2)</td><td align="char" rowspan="1" colspan="1">0.6754</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">SEP, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">04 (50.0)</td><td align="left" rowspan="1" colspan="1">07 (36.8)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:15%" align="left" rowspan="1" colspan="1">Tumor thickness &#x0003c; 1000 &#x000b5;m, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">03 (75.0)</td><td align="left" rowspan="1" colspan="1">4 (57.1)</td><td align="char" rowspan="1" colspan="1">1.0000</td></tr><tr><td style="padding-left:15%" align="left" rowspan="1" colspan="1">Tumor thickness &#x02265; 1000 &#x000b5;m), <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">01 (25.0)</td><td align="left" rowspan="1" colspan="1">3 (42.9)</td><td align="char" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Vascular invasion, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">00 (00.0)</td><td align="left" rowspan="1" colspan="1">00 (00.0)</td><td align="char" rowspan="1" colspan="1">0</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphatic invasion, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">00 (00.0)</td><td align="left" rowspan="1" colspan="1">01 (05.3)</td><td align="char" rowspan="1" colspan="1">1.0000</td></tr><tr><td align="left" rowspan="1" colspan="1">Adverse events</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="char" rowspan="1" colspan="1"/></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Laryngeal edema</td><td align="left" rowspan="1" colspan="1">06 (75.0)</td><td align="left" rowspan="1" colspan="1">16 (84.2)</td><td align="char" rowspan="1" colspan="1">0.6159</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Delayed bleeding, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">00 (00.0)</td><td align="left" rowspan="1" colspan="1">00 (00.0)</td><td align="char" rowspan="1" colspan="1">0</td></tr><tr><td style="padding-left:10%" align="left" rowspan="1" colspan="1">Dysphagia <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">03 (37.5)</td><td align="left" rowspan="1" colspan="1">05 (26.3)</td><td align="char" rowspan="1" colspan="1">0.6578</td></tr><tr><td align="left" rowspan="1" colspan="1">Local recurrence, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">01 (12.5)</td><td align="left" rowspan="1" colspan="1">00 (00.0)</td><td align="char" rowspan="1" colspan="1">0.2963</td></tr></tbody></table><table-wrap-foot><fn id="deo270003-tbl5-note-0001"><p>We compared the outcomes of the ESD&#x02010;alone (eight cases) and ELPS+ESD (19 cases) groups for lesions near the esophageal inlet.</p></fn><fn id="deo270003-tbl5-note-0002"><p>Abbreviations: CIS, carcinoma in situ; ELPS, endoscopic laryngo&#x02010;pharyngeal surgery; ESD, endoscopic submucosal resection; SD, standard deviation; SEP, subepithelial propria.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="deo270003-sec-0180"><title>Long&#x02010;term treatment outcomes</title><p>The long&#x02010;term prognoses for ESD and ELPS are summarized in Table&#x000a0;<xref rid="deo270003-tbl-0006" ref-type="table">6</xref> and Figure&#x000a0;<xref rid="deo270003-fig-0002" ref-type="fig">2</xref>. The observation period was longer in the ESD group than in the ELPS group (87.6 &#x000b1; 51.1 months vs. 37.7 &#x000b1; 23.8 months, <italic toggle="yes">p</italic> &#x0003c; 0.01). Furthermore, there was a significant difference in other disease mortality rates between the two groups (40.0% [14/35] vs. 18.3% [17/93], <italic toggle="yes">p</italic> &#x0003c; 0.01), and only one cause&#x02010;specific death occurred in the ESD group. The 3&#x02010;year overall survival (OS) rates for the ESD and ELPS groups were 94.1% and 85.5%, respectively. The 3&#x02010;year relapse&#x02010;free survival rates for the ESD and ELPS groups were 88.2% and 84.5%, respectively. Moreover, the 3&#x02010;year disease&#x02010;specific survival rates for the ESD and ELPS groups were 96.9% and 100%, respectively.</p><table-wrap position="float" id="deo270003-tbl-0006" content-type="TABLE"><label>TABLE 6</label><caption><p>Long&#x02010;term treatment outcomes of the endoscopic submucosal dissection and endoscopic laryngo&#x02010;pharyngeal surgery groups.</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">ESD group</th><th align="left" rowspan="1" colspan="1">ELPS group</th><th align="char" rowspan="1" colspan="1"/></tr><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Variables</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> = 35</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">n</italic> = 93</th><th align="left" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#x02010;value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Observation period (months), mean &#x000b1; SD</td><td align="left" rowspan="1" colspan="1">87.6 &#x000b1; 51.1</td><td align="left" rowspan="1" colspan="1">37.7 &#x000b1; 23.8</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Recurrences</td><td align="left" rowspan="1" colspan="1">02 (5.8)</td><td align="left" rowspan="1" colspan="1">05 (5.4)</td><td align="char" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Local recurrences, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">01 (2.9)</td><td align="left" rowspan="1" colspan="1">03 (3.2)</td><td align="char" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymph node metastases, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">01 (2.9)</td><td align="left" rowspan="1" colspan="1">02 (2.2)</td><td align="char" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Cause of death</td><td align="left" rowspan="1" colspan="1">15 (42.9)</td><td align="left" rowspan="1" colspan="1">17 (18.3)</td><td align="char" rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Cause&#x02010;specific death, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">01 (2.9)</td><td align="left" rowspan="1" colspan="1">00 (.0)</td><td align="char" rowspan="1" colspan="1">0.2734</td></tr><tr><td align="left" rowspan="1" colspan="1">Death of other diseases, <italic toggle="yes">n</italic> (%)</td><td align="left" rowspan="1" colspan="1">14 (40.0)</td><td align="left" rowspan="1" colspan="1">17 (18.3)</td><td align="char" rowspan="1" colspan="1">0.0192</td></tr><tr><td align="left" rowspan="1" colspan="1">3&#x02010;year OS</td><td align="left" rowspan="1" colspan="1">094.1</td><td align="left" rowspan="1" colspan="1">085.5</td><td align="char" rowspan="1" colspan="1">0.9473</td></tr><tr><td align="left" rowspan="1" colspan="1">3&#x02010;year RFS</td><td align="left" rowspan="1" colspan="1">088.2</td><td align="left" rowspan="1" colspan="1">084.5</td><td align="char" rowspan="1" colspan="1">0.9004</td></tr><tr><td align="left" rowspan="1" colspan="1">3&#x02010;year DSS</td><td align="left" rowspan="1" colspan="1">096.9</td><td align="left" rowspan="1" colspan="1">100.0</td><td align="char" rowspan="1" colspan="1">0.1541</td></tr></tbody></table><table-wrap-foot><fn id="deo270003-tbl6-note-0001"><p>We categorized all 128 lesions among the 93 patients into the ESD and ELPS groups. The ESD group includes 35 lesions among 29 patients. The ELPS group includes 93 lesions among 71 patients.</p></fn><fn id="deo270003-tbl6-note-0002"><p>Abbreviations: DSS, disease&#x02010;specific survival; ELPS, endoscopic laryngo&#x02010;pharyngeal surgery; ESD, endoscopic submucosal resection; OS, overall survival; RFS, relapse&#x02010;free survival; SD, standard deviation.</p></fn><fn id="deo270003-tbl6-note-0003"><label>*</label><p>Statistical significance was set at <italic toggle="yes">p</italic> &#x0003c; 0.05.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><fig position="float" fig-type="FIGURE" id="deo270003-fig-0002"><label>FIGURE 2</label><caption><p>(a) The 3&#x02010;year overall survival (OS) curves of the ESD and ELPS groups. (b) The 3&#x02010;year RFS curves of the ESD and ELPS groups. (c) The 3&#x02010;year DSS curves of the ESD and ELPS groups. OS, overall survival; ESD, endoscopic submucosal dissection; ELPS, endoscopic laryngo&#x02010;pharyngeal surgery; RFS, relapse&#x02010;free survival; DSS, disease&#x02010;specific survival.</p></caption><graphic xlink:href="DEO2-5-e70003-g002" position="anchor" id="jats-graphic-3"/></fig></sec></sec><sec id="deo270003-sec-0190"><title>DISCUSSION</title><p>Our study showed that there were no statistically significant differences in the complete en bloc resection rates and long&#x02010;term prognoses between the ELPS and ESD groups; however, the ELPS group had a shorter treatment time and lower incidence of laryngeal edema than did the ESD group. The ESD technique used in combination with the ELPS technique was beneficial in cases where the lesions were adjacent to the esophageal inlet patch.</p><p>Endoscopic treatments such as EMR, ESD, and ELPS are considered safe and effective in the treatment of SPCs. When compared to using EMR in the treatment of SPCs, ESD resulted in a higher percentage of en bloc and microscopically margin&#x02010;negative resections in which no gross or microscopic tumor remained in the primary tumor bed (R0 resections); however, the treatment time was longer.<xref rid="deo270003-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref>, <xref rid="deo270003-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>, <xref rid="deo270003-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> En bloc resection with a snare in the complex anatomy of the pharyngeal region is challenging, and the EMR en bloc resection rate is low. ESD has a higher en bloc resection rate than EMR; nevertheless, ESD is technically more challenging and requires a longer operative time due to its single&#x02010;arm endoscopy procedure.<xref rid="deo270003-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="deo270003-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>, <xref rid="deo270003-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>
</p><p>Nakayama et&#x000a0;al. reported that ELPS had the same resection rate but a shorter treatment time than that of ESD; their findings were similar to those of this study.<xref rid="deo270003-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> The concept of ELPS is similar to that of ESD in that the tumor is resected en bloc, subsequent to submucosal injection; however, it differs from ESD in that the resection technique is performed by a surgeon using both hands.<xref rid="deo270003-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> This allows the surgeon to manipulate the trans&#x02010;orally inserted forceps, grasp the lesion using the electrosurgical needle knife, and make a fine incision through the mucosa, while a clear view of the monitor is provided for the endoscopist. Resection with traction is essential because of the three&#x02010;dimensional anatomical features of the pharynx. ELPS allows for the use of both hands to adjust the direction of traction for resection, leading to a shorter treatment time.<xref rid="deo270003-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> Additionally, ELPS allows the depth of dissection to be adjusted, according to the endoscopically predicted depth of the tumor.<xref rid="deo270003-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> The subepithelial injection contributes to the preservation of deep structures. Thus, in lesions that are clearly diagnosable as intraepithelial lesions, minimizing resections can reduce unnecessary damage to the surrounding tissues and scar formation.<xref rid="deo270003-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> Additionally, B2 and B3 vessels of the JES classification and 0&#x02010;IIa and 0&#x02010;I of the macroscopic types are highly likely to be invasive carcinomas of the subepithelial propria (SEP). Moreover, an invasive distance of 1000 &#x000b5;m is an independent risk factor for cervical lymph node metastases.<xref rid="deo270003-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>, <xref rid="deo270003-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref>, <xref rid="deo270003-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Therefore, lesions with suspected SEP invasion should be dissected just above the muscle layer during ELPS for an en&#x02010;bloc resection. Regarding adverse events, there were no statistically significant differences in delayed bleeding or dysphagia between the two groups; however, laryngeal edema was less common in the ELPS group. Laryngeal edema is more likely to occur when the perilaryngeal local anesthetic injection volume is high, or with extended treatment time. The most effective method for reducing the amount of perilaryngeal local injection is exfoliation while applying traction, which allows for shorter treatment times.<xref rid="deo270003-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> ESD allows traction in only one direction with clip line traction, whereas ELPS allows traction in multiple directions with forceps. Therefore, ELPS may have reduced local injection volume, shortened treatment time, and reduced laryngeal edema, compared with ESD. Previous radiation therapy for head and neck cancer is an independent risk factor for laryngeal edema after endoscopic treatment of SPC.<xref rid="deo270003-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref> Therefore, in cases with risk factors for laryngeal edema, such as a history of post&#x02010;radiotherapy, it may be preferable to choose ELPS, which has a shorter treatment time and a lower local injection volume.</p><p>The ELPS technique can generally be performed in the treatment of most parts of the body; however, it does not suffice in narrow and difficult&#x02010;to&#x02010;treat areas, such as the esophageal inlet patch, supraglottis, and epiglottis valleys. Furthermore, narrow and complex structures, such as the pyriform sinus and tongue root, are risk factors for incomplete endoscopic en bloc resection.<xref rid="deo270003-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> ESD resection involves the use of a single instrument, such as the ESD knife or forceps, which can be applied to narrow areas, including adjacent to the esophageal inlet patch.<xref rid="deo270003-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> In our study, using the ESD technique in such areas made it easier to approach the narrow cavities directly with the scope, as well as to check and resect the edges of the lesion. Furthermore, R0 resections were made possible.<xref rid="deo270003-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref> Therefore, ESD can potentially be used in such cases. Hybrid treatment using the ELPS and ESD techniques is useful in cases of hypopharyngeal carcinomas that partially invade the esophageal inlet patch.<xref rid="deo270003-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="deo270003-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref>, <xref rid="deo270003-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref>, <xref rid="deo270003-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> In this study, we identified the need for ESD techniques in addition to ELPS in the treatment of the esophageal inlet patch, larynx, and glottis valley. We believe that the treatment of the sites identified in this study is a technical limitation of ELPS and that the addition of ESD techniques is necessary. The major advantage of endoscopic treatment with a curved rigid laryngoscope is that it provides a revolutionary wide view from the posterior cricoid to the cervical inlet patch, which is difficult to achieve using conventional methods.<xref rid="deo270003-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> The use of a laryngoscope also enabled the creation of a good field&#x02010;of&#x02010;view of the supraglottis, epiglottis, and tongue root, making it possible for ELPS to approach areas that are difficult to resect en bloc with ESD.<xref rid="deo270003-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> Owing to the varying shapes and sizes of the pharynx among patients, there are individualized differences in the areas where the instruments may interfere. Depending on the clinical situation, the use of either or both techniques is important.</p><p>In this study, the long&#x02010;term prognoses of the ESD and ELPS groups were comparable. There was no significant difference in the 3&#x02010;year survival rates between the two groups, and the survival subsequent to the use of the ELPS technique was comparable to that of ESD, as in previous reports.<xref rid="deo270003-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="deo270003-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> Additionally, there were cases of local recurrences and lymph node metastases; however, only one case of primary mortality occurred in the ESD group. In this study, death from other causes was predominantly observed in the ESD group compared to the ELPS group, but this may be due to the longer observation period. There was no significant difference in the 3&#x02010;year DSS rates between the two groups, and the rate for the ELPS group was 100%, similar to that in previous reports.<xref rid="deo270003-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref>, <xref rid="deo270003-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref>, <xref rid="deo270003-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref>, <xref rid="deo270003-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> In this study, salvage surgery or additional treatments were performed in most cases of local recurrences or lymph node metastases, and mortality from the primary disease was avoided. Pathologically positive margins are frequently caused by contusions from grasping or burning during excision; thus, local recurrence is not truly common in SPCs. Therefore, positive margins do not affect OS. However, in cases where there is a risk of local recurrence or lymph node metastases, follow&#x02010;up with periodic endoscopy, cervical ultrasonography, and computed tomography is essential, as salvage surgery or additional treatment should be performed as soon as possible.<xref rid="deo270003-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref>
</p><p>This study had certain limitations. This was a single&#x02010;center, retrospective study with a small sample size. Therefore, a large&#x02010;scale, multicenter, prospective study is required. The treatment choice after October 2014 may be a limitation as it was based on the endoscopist's and otolaryngologist's discretion. A significant difference was found in duration between the groups, and the endoscopists who performed pharyngeal ESD may have also performed ELPS, resulting in a difference in the technique proficiency. Furthermore, the amount of local injection has not been evaluated, although the laryngeal edema may be affected by the injection during the procedure.</p><p>In conclusion, no differences were found in the en bloc resection rates or long&#x02010;term outcomes between the ESD and ELPS groups. The ELPS group had a shorter treatment time and lower incidence of laryngeal edema than the ESD group. However, the treatment of narrow areas, such as the esophageal inlet patch, is a technical limitation of ELPS. Thus, ELPS should be combined with ESD techniques.</p></sec><sec sec-type="COI-statement" id="deo270003-sec-0200"><title>CONFLICT OF INTEREST STATEMENT</title><p>None.</p></sec><sec id="deo270003-sec-0230"><title>ETHICS STATEMENT</title><p>All enrolled participants were informed of the risks and benefits of ESD and ELPS and provided written informed consent for the use of their data. This study was approved by the Institutional Review Board of Hiroshima University Hospital (approval number: E2021&#x02010;2657) and was conducted in accordance with the principles of the Declaration of Helsinki.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="deo270003-supitem-0001" position="float" content-type="local-data"><caption><p>Supporting_Information_1 Details of definitions and pathological examinations.</p></caption><media xlink:href="DEO2-5-e70003-s001.docx"/></supplementary-material></sec></body><back><sec sec-type="data-availability" id="deo270003-sec-0220"><title>DATA AVAILABILITY STATEMENT</title><p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></sec><ref-list id="deo270003-bibl-0001"><title>REFERENCES</title><ref id="deo270003-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="deo270003-cit-0001">
<string-name>
<surname>Tateya</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Muto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Morita</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Endoscopic laryngo&#x02010;pharyngeal surgery for superficial laryngo&#x02010;pharyngeal cancer</article-title>. <source>Surg Endosc</source>
<year>2016</year>; <volume>30</volume>: <fpage>323</fpage>&#x02013;<lpage>329</lpage>.<pub-id pub-id-type="pmid">25917165</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="deo270003-cit-0002">
<string-name>
<surname>Adelstein</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Ridge</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Brizel</surname>
<given-names>DM</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6&#x02013;7, 2011, Arlington, Virginia</article-title>. <source>Head Neck</source>
<year>2012</year>; <volume>34</volume>: <fpage>1681</fpage>&#x02013;<lpage>1703</lpage>.<pub-id pub-id-type="pmid">23015475</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="deo270003-cit-0003">
<string-name>
<surname>Muto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nakane</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Katada</surname>
<given-names>C</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites</article-title>. <source>Cancer</source>
<year>2004</year>; <volume>101</volume>: <fpage>1375</fpage>&#x02013;<lpage>1381</lpage>.<pub-id pub-id-type="pmid">15368325</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="deo270003-cit-0004">
<string-name>
<surname>Katada</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Muto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Fujii</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Transoral surgery for superficial head and neck cancer: National Multi&#x02010;Center Survey in Japan</article-title>. <source>Cancer Med</source>
<year>2021</year>; <volume>10</volume>: <fpage>3848</fpage>&#x02013;<lpage>3861</lpage>.<pub-id pub-id-type="pmid">33991076</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="deo270003-cit-0005">
<string-name>
<surname>Kishimoto</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Sogami</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Uozumi</surname>
<given-names>R</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Complications after endoscopic laryngopharyngeal surgery</article-title>. <source>Laryngoscope</source>
<year>2018</year>; <volume>128</volume>: <fpage>1546</fpage>&#x02013;<lpage>1550</lpage>.<pub-id pub-id-type="pmid">28994120</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="deo270003-cit-0006">
<string-name>
<surname>Satou</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Omori</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Tagawa</surname>
<given-names>M</given-names>
</string-name>. <article-title>Treatment of superficial carcinoma in the hypopharynx</article-title>. <source>J Oto&#x02010;Rhino&#x02010;Laryngol Soc Jpn</source>
<year>2006</year>; <volume>109</volume>: <fpage>581</fpage>&#x02013;<lpage>586</lpage>.</mixed-citation></ref><ref id="deo270003-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="deo270003-cit-0007">
<string-name>
<surname>Kinjo</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Nonaka</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Oda</surname> I</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>The short&#x02010;term and long&#x02010;term outcomes of the endoscopic resection for the superficial pharyngeal squamous cell carcinoma</article-title>. <source>Endosc Int Open</source>
<year>2015</year>; <volume>3</volume>: <fpage>E266</fpage>&#x02013;<lpage>E273</lpage>.<pub-id pub-id-type="pmid">26357670</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="deo270003-cit-0008">
<string-name>
<surname>Nakayama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Katada</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mikami</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>A clinical study of transoral pharyngectomies to treat superficial hypopharyngeal cancers</article-title>. <source>Jpn J Clin Oncol</source>
<year>2013</year>; <volume>43</volume>: <fpage>782</fpage>&#x02013;<lpage>787</lpage>.<pub-id pub-id-type="pmid">23749982</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="deo270003-cit-0009">
<string-name>
<surname>Iizuka</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kikuchi</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hoteya</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Clinical advantage of endoscopic submucosal dissection over endoscopic mucosal resection for early mesopharyngeal and hypopharyngeal cancers</article-title>. <source>Endoscopy</source>
<year>2011</year>; <volume>43</volume>: <fpage>839</fpage>&#x02013;<lpage>843</lpage>.<pub-id pub-id-type="pmid">21833903</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="deo270003-cit-0010">
<string-name>
<surname>Muto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Satake</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yano</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Long&#x02010;term outcome of transoral organ&#x02010;preserving pharyngeal endoscopic resection for superficial pharyngeal cancer</article-title>. <source>Gastrointest Endosc</source>
<year>2011</year>; <volume>74</volume>: <fpage>477</fpage>&#x02013;<lpage>484</lpage>.<pub-id pub-id-type="pmid">21704994</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="deo270003-cit-0011">
<string-name>
<surname>Shimizu</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kato</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Endoscopic submucosal dissection for treatment of early stage hypopharyngeal carcinoma</article-title>. <source>Gastrointest Endosc</source>
<year>2006</year>; <volume>64</volume>: <fpage>255</fpage>&#x02013;<lpage>259</lpage>.<pub-id pub-id-type="pmid">16860078</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="deo270003-cit-0012">
<string-name>
<surname>Tateya</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Shiotani</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Satou</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Transoral surgery for laryngo&#x02010;pharyngeal cancer &#x02013; The paradigm shift of the head and cancer treatment</article-title>. <source>Auris Nasus Larynx</source>
<year>2016</year>; <volume>43</volume>: <fpage>21</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">26298233</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="deo270003-cit-0013">
<string-name>
<surname>Kawakubo</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tai Omori</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Mayanagi</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Indication of endoscopic treatment for superficial carcinoma of the cervical esophagus and pharynx</article-title>. <source>Stomach Intestine</source>
<year>2017</year>; <volume>52</volume>: <fpage>1706</fpage>&#x02013;<lpage>1714</lpage>.</mixed-citation></ref><ref id="deo270003-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="deo270003-cit-0014">
<string-name>
<surname>Tateya</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Morita</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ishikawa</surname>
<given-names>S</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Voice outcome in patients treated with endoscopic laryngopharyngeal surgery for superficial hypopharyngeal cancer</article-title>. <source>Clin Exp Otorhinolaryngol</source>
<year>2016</year>; <volume>9</volume>: <fpage>70</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">26976030</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="deo270003-cit-0015">
<string-name>
<surname>Tateya</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Morita</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Muto</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Magnifying endoscope with NBI to predict the depth of invasion in laryngo&#x02010;pharyngeal cancer</article-title>. <source>Laryngoscope</source>
<year>2015</year>; <volume>125</volume>: <fpage>1124</fpage>&#x02013;<lpage>1129</lpage>.<pub-id pub-id-type="pmid">25418330</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="deo270003-cit-0016">
<string-name>
<surname>Kikuchi</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Iizuka</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Yamada</surname>
<given-names>A</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Utility of magnifying endoscopy with narrow band imaging in determining the invasion depth of superficial pharyngeal cancer</article-title>. <source>Head Neck</source>
<year>2015</year>; <volume>37</volume>: <fpage>846</fpage>&#x02013;<lpage>850</lpage>.<pub-id pub-id-type="pmid">24623643</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="deo270003-cit-0017">
<string-name>
<surname>Imai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ito</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Oikawa</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Risk factors for cervical lymph node metastasis in endoscopically resected superficial hypopharyngeal cancers</article-title>. <source>Auris Nasus Larynx</source>
<year>2019</year>; <volume>46</volume>: <fpage>424</fpage>&#x02013;<lpage>430</lpage>.<pub-id pub-id-type="pmid">30249511</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="deo270003-cit-0018">
<string-name>
<surname>Iizuka</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kikuchi</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Hoteya</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Takeda</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kaise</surname>
<given-names>M</given-names>
</string-name>. <article-title>A new technique for pharyngeal endoscopic submucosal dissection: Peroral countertraction (with video)</article-title>. <source>Gastrointest Endosc</source>
<year>2012</year>; <volume>76</volume>: <fpage>1034</fpage>&#x02013;<lpage>1038</lpage>.<pub-id pub-id-type="pmid">22906853</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="deo270003-cit-0019">
<string-name>
<surname>Ominami</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Nagami</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kono</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Risk factors for adverse events associated with endoscopic submucosal dissection for superficial pharyngeal cancer</article-title>. <source>Surg Endosc</source>
<year>2023</year>; <volume>37</volume>: <fpage>6322</fpage>&#x02013;<lpage>6332</lpage>.<pub-id pub-id-type="pmid">37202526</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="deo270003-cit-0020">
<string-name>
<surname>Sakaguchi</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Saito</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ando</surname>
<given-names>M</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Risk factors for incomplete resection with pharyngeal endoscopic submucosal dissection and long&#x02010;term prognosis after resection</article-title>. <source>Surg Endosc</source>
<year>2023</year>; <volume>37</volume>: <fpage>3593</fpage>&#x02013;<lpage>3601</lpage>.<pub-id pub-id-type="pmid">36624214</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="deo270003-cit-0021">
<string-name>
<surname>Yamaguchi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Sato</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Tsukahara</surname>
<given-names>K</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Co&#x02010;treatment with endoscopic laryngopharyngeal surgery and endoscopic submucosal dissection</article-title>. <source>Auris Nasus Larynx</source>
<year>2021</year>; <volume>48</volume>: <fpage>457</fpage>&#x02013;<lpage>463</lpage>.<pub-id pub-id-type="pmid">33067052</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="deo270003-cit-0022">
<string-name>
<surname>Watanabe</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Taniguchi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kimura</surname>
<given-names>Y</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Synopsis of transoral endoscopic laryngopharyngeal surgery for superficial pharyngeal cancers</article-title>. <source>Head Neck</source>
<year>2017</year>; <volume>39</volume>: <fpage>1779</fpage>&#x02013;<lpage>1787</lpage>.<pub-id pub-id-type="pmid">28661556</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="deo270003-cit-0023">
<string-name>
<surname>Kawada</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Kawano</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Sugimoto</surname>
<given-names>T</given-names>
</string-name>
<italic toggle="yes">et&#x000a0;al.</italic>
<article-title>Case of superficial cancer located at the pharyngoesophageal junction which was dissected by endoscopic laryngopharyngeal surgery combined with endoscopic submucosal dissection</article-title>. <source>Case Rep Otolaryngol</source>
<year>2017</year>; <volume>2017</volume>: <fpage>1</fpage>&#x02013;<lpage>7</lpage>.</mixed-citation></ref><ref id="deo270003-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="deo270003-cit-0024">
<string-name>
<surname>Kishimoto</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tateya</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Funakoshi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Miyamoto</surname>
<given-names>SI</given-names>
</string-name>, <string-name>
<surname>Muto</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Omori</surname>
<given-names>K</given-names>
</string-name>. <article-title>Endoscopic laryngopharyngeal surgery for hypopharyngeal lesions</article-title>. <source>Oral Oncol</source>
<year>2020</year>; <volume>106</volume>: <elocation-id>104655</elocation-id>.<pub-id pub-id-type="pmid">32325303</pub-id>
</mixed-citation></ref><ref id="deo270003-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="deo270003-cit-0025">
<string-name>
<surname>Iizuka</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kikuchi</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Takeda</surname>
<given-names>H</given-names>
</string-name>. <article-title>Clinical relevance of endoscopic treatment for superficial pharyngeal cancer: Feasibility of techniques corresponding to each location and long&#x02010;term outcomes</article-title>. <source>Gastrointest Endosc</source>
<year>2021</year>; <volume>93</volume>: <fpage>818</fpage>&#x02013;<lpage>827</lpage>.<pub-id pub-id-type="pmid">32721490</pub-id>
</mixed-citation></ref></ref-list></back></article>